Approval · Notice of Compliance 31785 · 2023
SPIKEVAX: Notice of Compliance 31785
Issued October 4, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 31785
- Date
- October 4, 2023
- Company
- Moderna Biopharma Canada CorporationToronto, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative - Change in Product Ownership
Products in this notice
Medicinal ingredients
- ELASOMERAN 0.1 MG per ML
- ELASOMERAN 0.2 MG per ML